Furthermore, enhanced MEX-3 protein expression levels were reported after malignant transformation including gonadal cancers, suggesting that MEX-3 contributes to the tumor immune evasion, by directly targeting HLA-I and APM component encoding gene products, as summarized in Figure 4. This evidence concerns the gene MEX3D and neoplasm.